Back to search

Article

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

2020-09-11

Abstract excerpt

SARS-CoV-2 is a newly emergent coronavirus that causes COVID-19, which has adversely impacted human health and has led to a pandemic. There is an unmet need to develop therapies against SARS-CoV-2 due to its severity and lack of treatment options. A promising approach to combat COVID-19 is through the neutralization of SARS-CoV-2 by therapeutic antibodies. Previously, we described a strategy to rapidly identify an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a999222a-74f3-580a-ab97-46701122aaa7
DOI
10.21203/rs.3.rs-45225/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2DOI 10.21203/rs.3.rs-45225/v1
Select a neighboring publication to make it the new centre.